| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Revenue, net (includes 12.2 million and 15.5 million with related parties for the three months ended september30, 2025 and 2024, respectively, and 42.9 million and 39.5 million with related parties for the nine months ended september30, 2025 and 2024, respectively) | 659,903 | 603,311 | - | 533,317 |
| Direct Costs | 186,335 | 185,826 | - | - |
| Reimbursable Out Of Pocket Costs | 276,629 | 237,472 | - | - |
| Total direct costs | 462,964 | 423,298 | - | 364,309 |
| Selling, general and administrative | 48,082 | 46,664 | - | 49,217 |
| Depreciation | 6,813 | 6,777 | - | 7,158 |
| Amortization | 236 | 237 | - | 360 |
| Total operating expenses | 518,095 | 476,976 | - | 421,044 |
| Income from operations | 141,808 | 126,335 | 113,523 | 112,273 |
| Miscellaneous (expense) income, net | -489 | -2,875 | -1,816 | -1,025 |
| Interest income, net | 1,517 | 1,078 | 6,463 | 7,528 |
| Total other income, net | 1,028 | -1,797 | 4,647 | 6,503 |
| Income before income taxes | 142,836 | 124,538 | 118,170 | 118,776 |
| Income tax provision | 31,701 | 34,278 | 3,575 | 22,350 |
| Net income | 111,135 | 90,260 | 114,595 | 96,426 |
| Basic (in dollars per share) | 3.95 | 3.16 | 3.77 | 3.11 |
| Basic (in shares) | 28,136,000 | 28,601,000 | 30,387,000 | 31,047,000 |
| Diluted (in dollars per share) | 3.86 | 3.1 | 3.67 | 3.01 |
| Diluted (in shares) | 28,817,000 | 29,143,000 | 31,196,000 | 32,088,000 |
Medpace Holdings, Inc. (MEDP)
Medpace Holdings, Inc. (MEDP)